Lamdong Pharmaceutical JSC (HNX:LDP)
Vietnam · Delayed Price · Currency is VND 9,300.00
-800.00 (-7.92%)
At close: Jan 30, 2026
HNX:LDP Revenue
In the year 2025, Lamdong Pharmaceutical JSC had annual revenue of 243.91B VND with 11.91% growth. Lamdong Pharmaceutical JSC had revenue of 73.81B in the quarter ending December 31, 2025, with 2.81% growth.
Revenue
243.91B
Revenue Growth
+11.91%
P/S Ratio
0.70
Revenue / Employee
987.48M
Employees
247
Market Cap
170.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 243.91B | 25.95B | 11.91% |
| Dec 31, 2024 | 217.96B | 31.96B | 17.18% |
| Dec 31, 2023 | 186.00B | -1.41B | -0.75% |
| Dec 31, 2022 | 187.41B | 25.51B | 15.76% |
| Dec 31, 2021 | 161.90B | -217.76B | -57.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Vimedimex Medi-Pharma JSC | 1.17T |
| OPC Pharmaceutical JSC | 1.06T |
| Vidipha Central Pharmaceutical JSC | 950.89B |
| Ben Tre Pharmaceutical JSC | 839.79B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Mediplantex National Pharmaceutical JSC | 367.08B |